Development of gene polymorphisms in meditators of nonalcoholic fatty liver disease (Review)
- Authors:
- Chun Wang
- Jianping Gong
- Hao Wu
-
Affiliations: Department of General Surgery, Yongchuan Hospital of Traditional Chinese Medicine, Chongqing 402161, P.R. China, Department of Hepatobiliary Surgery, The Second Affiliated Hospital, Chongqing Medical University, Chongqing 400010, P.R. China - Published online on: June 14, 2017 https://doi.org/10.3892/br.2017.926
- Pages: 95-104
This article is mentioned in:
Abstract
 |
|
Zhang X, Harmsen WS, Mettler TA, Kim WR, Roberts RO, Therneau TM, Roberts LR and Chaiteerakij R: Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes. Hepatology. 60:2008–2016. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Day CP and James OF: Steatohepatitis: A tale of two ‘hits’? Gastroenterology. 114:842–845. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Anstee QM, Daly AK and Day CP: Genetics of alcoholic and nonalcoholic fatty liver disease. Semin Liver Dis. 31:128–146. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Lake AD, Novak P, Hardwick RN, Flores-Keown B, Zhao F, Klimecki WT and Cherrington NJ: The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease. Toxicol Sci. 137:26–35. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Anderson N and Borlak J: Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis. Pharmacol Rev. 60:311–357. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Naik A, Belič A, Zanger UM and Rozman D: Molecular interactions between NAFLD and xenobiotic metabolism. Front Genet. 4:22013. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang D, Liu ZX, Choi CS, Tian L, Kibbey R, Dong J, Cline GW, Wood PA and Shulman GI: Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance. Proc Natl Acad Sci USA. 104:17075–17080. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Duvnjak M, Lerotić I, Barsić N, Tomasić V, Jukić L Virović and Velagić V: Pathogenesis and management issues for non-alcoholic fatty liver disease. World J Gastroenterol. 13:4539–4550. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Bradbury MW and Berk PD: Lipid metabolism in hepatic steatosis. Clin Liver Dis. 8639–671. (xi)2004. View Article : Google Scholar : PubMed/NCBI | |
|
de Almeida IT, Cortez-Pinto H, Fidalgo G, Rodrigues D and Camilo ME: Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis. Clin Nutr. 21:219–223. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Malaguarnera L, Di Rosa M, Zambito AM, dell'Ombra N, Nicoletti F and Malaguarnera M: Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease. Gut. 55:1313–1320. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K and Tobe K: Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 116:1784–1792. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Müssig K, Heni M, Thamer C, Kantartzis K, Machicao F, Stefan N, Fritsche A, Häring HU and Staiger H: The ENPP1 K121Q polymorphism determines individual susceptibility to the insulin-sensitising effect of lifestyle intervention. Diabetologia. 53:504–509. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Dongiovanni P, Valenti L, Rametta R, Daly AK, Nobili V, Mozzi E, Leathart JB, Pietrobattista A, Burt AD, Maggioni M, et al: Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease. Gut. 59:267–273. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Parola M and Marra F: Adipokines and redox signaling: Impact on fatty liver disease. Antioxid Redox Signal. 15:461–483. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Tokushige K, Hashimoto E, Noto H, Yatsuji S, Taniai M, Torii N and Shiratori K: Influence of adiponectin gene polymorphisms in Japanese patients with non-alcoholic fatty liver disease. J Gastroenterol. 44:976–982. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Wong VW, Wong GL, Tsang SW, Hui AY, Chan AW, Choi PC, So WY, Tse AM, Chan FK, Sung JJ, et al: Genetic polymorphisms of adiponectin and tumor necrosis factor-alpha and nonalcoholic fatty liver disease in Chinese people. J Gastroenterol Hepatol. 23:914–921. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Wang BF, Wang Y, Ao R, Tong J and Wang BY: AdipoQ T45 G and G276 T polymorphisms and susceptibility to nonalcoholic fatty liver disease among Asian populations: A meta-analysis and meta-regression. J Clin Lab Anal. 30:47–57. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Hashemi M, Bojd H Hanafi, Nasab E Eskandari, Bahari A, Hashemzehi NA, Shafieipour S, Narouie B, Taheri M and Ghavami S: Association of adiponectin rs1501299 and rs266729 gene polymorphisms with nonalcoholic fatty liver disease. Hepat Mon. 13:e95272013. View Article : Google Scholar : PubMed/NCBI | |
|
Muse ED, Obici S, Bhanot S, Monia BP, McKay RA, Rajala MW, Scherer PE and Rossetti L: Role of resistin in diet-induced hepatic insulin resistance. J Clin Invest. 114:232–239. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Singhal NS, Patel RT, Qi Y, Lee YS and Ahima RS: Loss of resistin ameliorates hyperlipidemia and hepatic steatosis in leptin-deficient mice. Am J Physiol Endocrinol Metab. 295:E331–E338. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Tomaru T, Steger DJ, Lefterova MI, Schupp M and Lazar MA: Adipocyte-specific expression of murine resistin is mediated by synergism between peroxisome proliferator-activated receptor gamma and CCAAT/enhancer-binding proteins. J Biol Chem. 284:6116–6125. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Kumar S, Gupta V, Srivastava N, Gupta V, Mishra S, Mishra S, Shankar M Natu, Roy U, Chandra A, Negi MP, et al: Resistin 420C/G gene polymorphism on circulating resistin, metabolic risk factors and insulin resistance in adult women. Immunol Lett. 162(2 Pt B): 287–291. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang LY, Jin YJ, Jin QS, Lin LY, Zhang DD and Kong LL: Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus. Gene. 529:340–344. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
El-Shal AS, Pasha HF and Rashad NM: Association of resistin gene polymorphisms with insulin resistance in Egyptian obese patients. Gene. 515:233–238. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Lu H, Sun J, Sun L, Shu X, Xu Y and Xie D: Polymorphism of human leptin receptor gene is associated with type 2 diabetic patients complicated with non-alcoholic fatty liver disease in China. J Gastroenterol Hepatol. 24:228–232. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Swellam M and Hamdy N: Association of nonalcoholic fatty liver disease with a single nucleotide polymorphism on the gene encoding leptin receptor. IUBMB Life. 64:180–186. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zain SM, Mohamed Z, Mahadeva S, Cheah PL, Rampal S, Chin KF, Mahfudz AS, Basu RC, Tan HL and Mohamed R: Impact of leptin receptor gene variants on risk of non-alcoholic fatty liver disease and its interaction with adiponutrin gene. J Gastroenterol Hepatol. 28:873–879. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Brondani LA, Assmann TS, de Souza BM, Bouças AP, Canani LH and Crispim D: Meta-analysis reveals the association of common variants in the uncoupling protein (UCP) 1–3 genes with body mass index variability. PLoS One. 9:e964112014. View Article : Google Scholar : PubMed/NCBI | |
|
Mexitalia M, Yamauchi T, Utari A, Sjarif DR, Subagio HW, Soemantri A and Ishida T: The role of uncoupling protein 2 and 3 genes polymorphism and energy expenditure in obese Indonesian children. J Pediatr Endocrinol Metab. 26:441–447. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Xu YP, Liang L, Wang CL, Fu JF, Liu PN, Lv LQ and Zhu YM: Association between UCP3 gene polymorphisms and nonalcoholic fatty liver disease in Chinese children. World J Gastroenterol. 19:5897–5903. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Hashemi M, Hoseini H, Yaghmaei P, Moazeni-Roodi A, Bahari A, Hashemzehi N and Shafieipour S: Association of polymorphisms in glutamate-cysteine ligase catalytic subunit and microsomal triglyceride transfer protein genes with nonalcoholic fatty liver disease. DNA Cell Biol. 30:569–575. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Tian Y, Li H, Wang S, Yan J, Chen Z, Li Z, Feng H, Zhou H and Ouyang D: Association of L-FABP T94A and MTP I128T polymorphisms with hyperlipidemia in Chinese subjects. Lipids. 50:275–282. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Peng XE, Wu YL, Lu QQ, Hu ZJ and Lin X: MTTP polymorphisms and susceptibility to non-alcoholic fatty liver disease in a Han Chinese population. Liver Int. 34:118–128. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Gambino R, Cassader M, Pagano G, Durazzo M and Musso G: Polymorphism in microsomal triglyceride transfer protein: A link between liver disease and atherogenic postprandial lipid profile in NASH? Hepatology. 45:1097–1107. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Wolff E, Vergnes MF, Defoort C, Planells R, Portugal H, Nicolay A and Lairon D: Cholesterol absorption status and fasting plasma cholesterol are modulated by the microsomal triacylglycerol transfer protein −493 G/T polymorphism and the usual diet in women. Genes Nutr. 6:71–79. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Siqueira ER, Oliveira CP, Correa-Giannella ML, Stefano JT, Cavaleiro AM, Fortes MA, Muniz MT, Silva FS, Pereira LM and Carrilho FJ: MTP −493G/T gene polymorphism is associated with steatosis in hepatitis C-infected patients. Braz J Med Biol Res. 45:72–77. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Dongiovanni P, Rametta R, Fracanzani AL, Benedan L, Borroni V, Maggioni P, Maggioni M, Fargion S and Valenti L: Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: Α case control study. BMC Gastroenterol. 10:1022010. View Article : Google Scholar : PubMed/NCBI | |
|
Stienstra R, Saudale F, Duval C, Keshtkar S, Groener JE, van Rooijen N, Staels B, Kersten S and Müller M: Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity. Hepatology. 51:511–522. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Chen S, Li Y, Li S and Yu C: A Val227Ala substitution in the peroxisome proliferator activated receptor alpha (PPAR alpha) gene associated with non-alcoholic fatty liver disease and decreased waist circumference and waist-to-hip ratio. J Gastroenterol Hepatol. 23:1415–1418. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Naito H, Yamanoshita O, Kamijima M, Katoh T, Matsunaga T, Lee CH, Kim H, Aoyama T, Gonzalez FJ and Nakajima T: Association of V227A PPARalpha polymorphism with altered serum biochemistry and alcohol drinking in Japanese men. Pharmacogenet Genomics. 16:569–577. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Domenici FA, Brochado MJ, Martinelli AL, Zucoloto S, da Cunha SF and Vannucchi H: Peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms in nonalcoholic fatty liver disease: A study in Brazilian patients. Gene. 529:326–331. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Sahebkar A: Does PPARγ2 gene Pro12Ala polymorphism affect nonalcoholic fatty liver disease risk? Evidence from a meta-analysis. DNA Cell Biol. 32:188–198. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Yang Z, Wen J, Li Q, Tao X, Ye Z, He M, Zhang W, Huang Y, Chen L, Ling C, et al: PPARG gene Pro12Ala variant contributes to the development of non-alcoholic fatty liver in middle-aged and older Chinese population. Mol Cell Endocrinol. 348:255–259. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Cao CY, Li YY, Zhou YJ, Nie YQ and Wan YJ: The C-681G polymorphism of the PPAR-γ gene is associated with susceptibility to non-alcoholic fatty liver disease. Tohoku J Exp Med. 227:253–262. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Gawrieh S, Marion MC, Komorowski R, Wallace J, Charlton M, Kissebah A, Langefeld CD and Olivier M: Genetic variation in the peroxisome proliferator activated receptor-gamma gene is associated with histologically advanced NAFLD. Dig Dis Sci. 57:952–957. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Bien CM and Espenshade PJ: Sterol regulatory element binding proteins in fungi: Hypoxic transcription factors linked to pathogenesis. Eukaryot Cell. 9:352–359. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Nagaya T, Tanaka N, Suzuki T, Sano K, Horiuchi A, Komatsu M, Nakajima T, Nishizawa T, Joshita S, Umemura T, et al: Down-regulation of SREBP-1c is associated with the development of burned-out NASH. J Hepatol. 53:724–731. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Tong J, Chang B, Wang BF, Zhang D and Wang BY: Relationship of SREBP-2 rs2228314 G>C polymorphism with nonalcoholic fatty liver disease in a Han Chinese population. Genet Test Mol Biomarkers. 18:653–657. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Sun S, Wang M, Song H, Wu T, Wei H, He S, Ding Z and Ji G: SCAP gene polymorphisms decrease the risk of nonalcoholic fatty liver disease in females with metabolic syndrome. J Genet. 92:565–570. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Younossi ZM, Gorreta F, Ong JP, Schlauch K, Del Giacco L, Elariny H, van Meter A, Younoszai A, Goodman Z, Baranova A, et al: Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis. Liver Int. 25:760–771. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Al-Serri A, Anstee QM, Valenti L, Nobili V, Leathart JB, Dongiovanni P, Patch J, Fracanzani A, Fargion S, Day CP, et al: The SOD2 C47T polymorphism influences NAFLD fibrosis severity: Evidence from case-control and intra-familial allele association studies. J Hepatol. 56:448–454. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Krautbauer S, Eisinger K, Lupke M, Wanninger J, Ruemmele P, Hader Y, Weiss TS and Buechler C: Manganese superoxide dismutase is reduced in the liver of male but not female humans and rodents with non-alcoholic fatty liver disease. Exp Mol Pathol. 95:330–335. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Nahon P, Sutton A, Rufat P, Ziol M, Akouche H, Laguillier C, Charnaux N, Ganne-Carrié N, Grando-Lemaire V, N'Kontchou G, et al: Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis. Hepatology. 50:1484–1493. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Kathirvel E, Chen P, Morgan K, French SW and Morgan TR: Oxidative stress and regulation of anti-oxidant enzymes in cytochrome P4502E1 transgenic mouse model of non-alcoholic fatty liver. J Gastroenterol Hepatol. 25:1136–1143. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Liu W, Tian F, Dai L and Chai Y: Cytochrome P450 2E1 gene polymorphism and alcohol drinking on the risk of hepatocellular carcinoma: A meta-analysis. Mol Biol Rep. 41:7645–7650. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Khan AJ, Ruwali M, Choudhuri G, Mathur N, Husain Q and Parmar D: Polymorphism in cytochrome P450 2E1 and interaction with other genetic risk factors and susceptibility to alcoholic liver cirrhosis. Mutat Res. 664:55–63. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Handa P, Morgan-Stevenson V, Maliken BD, Nelson JE, Washington S, Westerman M, Yeh MM and Kowdley KV: Iron overload results in hepatic oxidative stress, immune cell activation, and hepatocellular ballooning injury, leading to nonalcoholic steatohepatitis in genetically obese mice. Am J Physiol Gastrointest Liver Physiol. 310:G117–G127. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Nelson JE, Brunt EM and Kowdley KV: Nonalcoholic Steatohepatitis Clinical Research Network: Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations. Hepatology. 56:1730–1740. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Lee SH, Jeong SH, Lee D, Lee JH, Hwang SH, Cho YA, Park YS, Hwang JH, Kim JW, Kim N, et al: An epidemiologic study on the incidence and significance of HFE mutations in a Korean cohort with nonalcoholic fatty liver disease. J Clin Gastroenterol. 44:e154–e161. 2010.PubMed/NCBI | |
|
Nelson JE, Yeh MM and Kowdley KV: Relationship of C282Y HFE mutations, hepatic iron deposition and histologic features in patients with nonalcoholic fatty liver disease. Gastroenterology. 140:S938–S939. 2011. | |
|
Valenti L, Fracanzani AL, Bugianesi E, Dongiovanni P, Galmozzi E, Vanni E, Canavesi E, Lattuada E, Roviaro G, Marchesini G, et al: HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 138:905–912. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Rivera CA, Adegboyega P, van Rooijen N, Tagalicud A, Allman M and Wallace M: Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J Hepatol. 47:571–579. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Nagaya T, Tanaka N, Kimura T, Komatsu M and Tanaka E: Enhanced expression of toll-like receptor 4 and MyD88 is associated with disease progression in human nonalcoholic fatty liver disease. Gastroenterology. 140:S–978. 2011. | |
|
Thuy S, Ladurner R, Volynets V, Wagner S, Strahl S, Königsrainer A, Maier KP, Bischoff SC and Bergheim I: Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr. 138:1452–1455. 2008.PubMed/NCBI | |
|
Peng D, Jiang F, Zhang R, Tang S, Chen M, Yan J, Sun X, Luo Y, Hu C and Jia W: Association of Toll-like Receptor 4 Gene polymorphisms with susceptibility to type 2 diabetes mellitus in the Chinese population. J Diabetes. 7:485–492. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Yin YW, Wang Q, Sun QQ, Hu AM and Liu HL: Toll-like receptor 4 gene Asp299Gly and Thr399Ile polymorphisms in type 2 diabetes mellitus: A meta-analysis of 15,059 subjects. Diabetes Res Clin Pract. 107:338–347. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Kiziltas S, Ata P, Colak Y, Mesçi B, Senates E, Enc F, Ulasoglu C, Tuncer I and Oguz A: TLR4 gene polymorphism in patients with nonalcoholic fatty liver disease in comparison to healthy controls. Metab Syndr Relat Disord. 12:165–170. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Tache D, Bogdan F, Pisoschi C, Baniţă M, Stănciulescu C, Fusaru AM and Comănescu V: Evidence for the involvement of TGF-β1-CTGF axis in liver fibrogenesis secondary to hepatic viral infection. Rom J Morphol Embryol. 52:409–412. 2011.PubMed/NCBI | |
|
Xiang TX, Cheng N, Li XN and Wu XP: Association between transforming growth factor-β1 polymorphisms and hepatocellular cancer risk: A meta-analysis. Hepatol Res. 42:583–590. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Mohy A and Fouad A: Role of transforming growth factor-β1 in serum and − 509 C>T promoter gene polymorphism in development of liver cirrhosis in Egyptian patients. Meta Gene. 2:631–637. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Falleti E, Fabris C, Toniutto P, Fontanini E, Cussigh A, Bitetto D, Fornasiere E, Avellini C, Minisini R and Pirisi M: TGF-β1 genotypes in cirrhosis: Relationship with the occurrence of liver cancer. Cytokine. 44:256–261. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Dai CY, Chuang WL, Lee LP, Pan WC, Huang JF, Hsieh MY, Hou NJ, Lin ZY, Chen SC, Hsieh MY, et al: Association between transforming growth factor-beta 1 polymorphism and virologic characteristics of chronic hepatitis C. Transl Res. 152:151–156. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Valenti L, Fracanzani AL, Dongiovanni P, Santorelli G, Branchi A, Taioli E, Fiorelli G and Fargion S: Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease. Gastroenterology. 122:274–280. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Tokushige K, Takakura M, Tsuchiya-Matsushita N, Taniai M, Hashimoto E and Shiratori K: Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis. J Hepatol. 46:1104–1110. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Wang JK, Feng ZW, Li YC, Li QY and Tao XY: Association of tumor necrosis factor-α gene promoter polymorphism at sites −308 and −238 with non-alcoholic fatty liver disease: A meta-analysis. J Gastroenterol Hepatol. 27:670–676. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Wei Y, Liu F, Li B, Chen X, Ma Y, Yan L, Wen T, Xu M, Wang W and Yang J: Polymorphisms of tumor necrosis factor-alpha and hepatocellular carcinoma risk: A HuGE systematic review and meta-analysis. Dig Dis Sci. 56:2227–2236. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Marginean O, Banescu C, Duicu C, Marginean M Oana and Marginean C: The role of interleukin-6 gene 572G/C polymorphism in child obesity. Clin Nutr. 33:S1172014. View Article : Google Scholar | |
|
Giannitrapani L, Soresi M, Balasus D, Licata A and Montalto G: Genetic association of interleukin-6 polymorphism (−174 G/C) with chronic liver diseases and hepatocellular carcinoma. World J Gastroenterol. 19:2449–2455. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Deng Y, Li M, Wang J, Xie L, Li T, He Y, Lu Q, Li R, Tan A, Qin X, et al: Susceptibility to hepatocellular carcinoma in the Chinese population-associations with interleukin-6 receptor polymorphism. Tumour Biol. 35:6383–6388. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G and Bellentani S: Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study. Hepatology. 42:44–52. 2005. View Article : Google Scholar : PubMed/NCBI |
